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Executive Summary
1. Purpose
This report presents the results from a scoping exercise 
led by Aberystwyth University, funded by ASPECT. ASPECT 
provides specialist support for organisations looking to 
make the most of commercial and business opportunities 
from social sciences research. This piece of research 
aims to scope perceived opportunities, contributions, 
barriers, and facilitators of collaboration between social 
sciences researchers and the health tech industry. It has 
been carried out as part of a deep dive study to inform 
best practice for business engagement with the sector. 
2. Recommendations
From the insights gained during this research project, we 
recommend the following to encourage and develop the 
environment for a successful collaboration:
1. Increase funding opportunities which encourage and/
or require social sciences academia and health tech 
industry collaborations.
2. Drive up engagement between the health tech 
industry and social sciences academia. 
For example:
a. Match making or networking events, to enable 
better understanding of each other’s skills, 
expectations and needs.
b. Virtual poster sessions with facilitated Q & A time 
with the innovator and/or project team.
c. Webinars sharing results of ongoing collaborations 
with opportunity for interaction.  
3. Encouraging collaboration earlier in the product 
development process to gain maximum benefit from 
meaningful engagement. 
Practically this could include:
a. Raising awareness through continuing to develop, 
publish and share case studies through existing 
networks and groups such as; ASPECT, The Life 
Sciences Hub, The ABPI, BIA, MedTech Europe.
b. Set up specific outlets by which to share these 
examples and testimonials, e.g. Via LinkedIn open 
groups that people could follow. 
c. Encourage a university / academic wide approach 
by providing some templates to easily gather 
feedback and document case studies after a 
project which would allow a uniform approach.
d. Proactively follow up with industry / academic 
partners.
3. Introduction 
This report explores benefits and barriers affecting 
collaborations between social sciences academics and 
the health tech industry. The research data was collected 
via a small-scale online survey and 10 in-depth interviews1. 
The small-scale online survey was conducted and 
disseminated to academics in the social sciences and 
individuals within the health tech sector. The survey 
consisted of open-ended questions investigating 
the perceptions of the role of social science within 
the health tech industry, barriers and facilitators to 
collaboration and specific collaborative experiences. 
It was disseminated using email and social media to 
the networks of ASPECT and Aberystwyth University. This 
included university partners, Welsh Government, and 
industry contacts. 
The interviews were conducted by Gatehouse ICS, 
an independent healthcare research agency, with 
individuals who have been involved in collaborations 
between the health tech industry and social sciences 
academics. The interviewees were equally split; 5 
individuals from academia and 5 from the health tech 
industry or implementation organisations (such as the 
NHS). The interview discussion guide was composed of 
open-ended questions with probes to facilitate natural 
discussions about the collaboration, focusing on barriers, 
benefits, learnings and recommendations. 
From these interviews, we have created 5 case study 
exemplars of successful collaboration projects. 
Section 5 of this report looks in-depth at the benefits 
of collaborating with the health tech industry and with 
social sciences academia; barriers to be overcome; 
key components of a good collaboration; multi-partner 
collaborations; and, the impact of COVID-19.
1.  Research ethics approvals were provided by Aberystwyth University’s psychology department ethics committee [ref. number 19054]
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The data from the survey responses and interviews have 
been analysed, the results and insights are presented 
in this report. Firstly, we will present the broad survey 
findings. Followed by the more in-depth interview insights, 
leading into the 5 case study exemplars. Concluding by 
drawing together the key findings from the survey and 
interviews. Recommendations from these conclusions are 
given in the executive summary in section 2, page 3. 
4. Online Survey
Responses to the online survey include 5 individuals from 
a variety of different areas of social science including 
psychology, social work, business and ethics of science 
and technology, with 2 responses from the health tech 
industry including areas such as artificial intelligence, 
telemedicine, mobile health development and software 
development. The table below summarises participants 
responses around aspects of relevance, perceptions, and 
collaboration. 
Academia Respondents Health-tech Respondents
Perceived  
relevance of social 
science research 
to the health tech 
industry
The view that social science has  
significant relevance for the health tech 
industry but that collaborations and 
knowledge exchange at different stages 
needs to be meaningful to be beneficial. 
The view that social science has 
significant relevance at different stages 
including design, deployment and 
transferring technology from a market to 
an environmental context. 
Perception of  
social science 
research or health 
tech industry of  
one another
Perceptions are mixed, with the 
overarching view that social science is 
perceived negatively, potentially rooted 
in comparisons between social science 
with harder sciences. On the other hand, 
recognition that this is dependent on 
different companies, and the relationship 
between the sectors is still new and 
developing. 
Perceptions are mixed with views that the 
health tech industry needs to be more 
accommodating.
View that social sciences perceive the 
health tech industry as academically 
dull, focused more on practicalities and 
bound by regulatory and commercial 
pressures. 
Available methods 
to identify partners 
for collaboration
Methods for identifying partners include 
predominately business development 
officers within universities and word of 
mouth. 
Methods for identifying partners focus 
on private networks developed by team 
project members alongside different 
organisations and initiatives that drove 
cross discipline collaboration (e.g., 
Swansea University’s Life Sciences Hub).  
Key challenges  
for collaboration
Lack of understanding of each other’s 
needs, to include; differing values and  
expectations, methodological 
approaches, timescales of work/research.
Lack of opportunities for cross discipline 
events to network and collaborate.
Lack of appropriate funding for 
technology- based projects or to enable 
access to products/licences for research.
Lack of funds for new start-ups seeking 
collaboration to commission / fund 
research. 
Differing views about the need for 
commercial success for impact.
Key benefits of  
collaboration
Opportunities for industry to benefit from 
insights during all stages of  
the process.
Industry gain the opportunity to  
improve products making them more 
commercially viable.
Providing credibility/legitimacy  
for products.
Access to new perspectives, insights,  
skills and research resources  
otherwise unavailable.
Opportunity for external support and 
promotion through academic contacts.
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4.1 Insights from the survey
The aim of the survey was to generate broad views 
of the sectors in question. Unfortunately, the survey 
returns were lower than anticipated given the limited 
time scales of the research and as such are not 
necessarily generalisable to the wider sector. However, 
the challenges of recruitment echo the sentiments 
of participants, that identifying and reaching suitable 
collaborative partners is a key challenge in this sector. 
There was agreement that social science research 
has a valuable role to play in the health tech industry. 
This was recognised to be from early product design 
and development, through to user engagement and 
evaluation. Interestingly, little discussion was had about 
the potential benefits that collaborating with health 
tech industry offered social science in the form of 
opportunities for theoretical application and research 
impact and may warrant further promotion. 
However, each party felt that their own discipline 
was viewed negatively, either being considered 
less scientifically rigorous (social science view) or 
academically dull and money focused (industry view). 
This likely stemmed from the lack of networking events 
or platforms where individuals could identify partners, 
explore the opportunities for collaboration and develop a 
better understanding of each other’s skills and needs. 
Souring collaborative opportunities was seen to be 
particularly challenging for small companies or new 
start-ups where research budgets were unavailable. 
Academics also voiced concerns that limited funding 
streams existed to support engagement with this type of 
research. 
5. In-depth insights  
from the interviews
The following themes and insights have been collated 
from the 10 interviews, which focused on the individual’s 
experience(s) of collaborations between the health 
tech industry and social sciences academia. These 
collaborations often included partners from other sectors, 
such as the NHS, third sector, local government and other 
academic disciplines. Therefore, many of these themes 
can be viewed more widely as benefits, barriers and key 
components for multi-partner collaborations.
The points below are paraphrased and/or summarised 
insights from responses given in the interviews. Direct 
quotes have been presented in anonymous “quoted 
italics” to further expand and add detail, we have 
indicated whether the quote was from a social sciences 
academic by (academia) or an industry or implementing 
partner by (non-academia). 
5.1 Benefits of collaborating 
with the health tech industry
5.1.1 Increasing accessibility 
to academic research 
• Technology provides an opportunity for academically 
proven results to reach the general public and gets the 
research out into the real world, beyond the walls of 
academia. For example, enabling interventions to be 
delivered through a method which is regularly used in 
daily life – e.g a mobile phone App. 
“Normalisation and accessibility are key in successful 
interventions.” (academia)
• Technology provides live feedback possibilities, which 
can support quicker and easier collection of evidence 
in academic research projects / trials. 
5.1.2 Increasing opportunities 
for collaborations
• The health tech industry is evolving, approximately 3-4 
years ago there were a number of big players, now 
there are a lot of very specialist health tech providers. 
Increasing the number of potential collaborations of 
value to all partners.
• There is an increasing pressure for commercial health 
tech companies to prove that they support and 
develop innovations which have a long term aim to 
meet the needs of the population.  
• A large volume of the population is already open and 
willing to use Technology Enabled Care (TEC). This 
increases the opportunities for academic research 
collaborations and development of evidence-based 
TEC which will deliver a measurable difference in 
people’s lives.
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5.2 Benefits of collaborating 
with social sciences academia
5.2.1 Deliver independent 
credible analysis 
• Analysis conducted by an academic team ensures 
that the objective of the outcomes are independent 
and not commercially linked or focussed.
• Provides data to support outcomes and deliverables of 
the technology.
“Evaluation is everything and too much of what is done 
in the world is not evaluated properly therefore it isn’t 
improved as much as it could be.” (non-academia)
5.2.2 Access to  
university network 
• Provides and expands access to multi- / inter– 
disciplinary teams. 
• Provides access to independent specialists and 
generalists, who are able to have open conversations 
and give honest feedback, willing to say “x needs 
changing”. 
• Provides access to networking events and 
opportunities with the wider university network.
“Smaller universities tend to be easier to work with 
because they are small enough to work efficiently 
and effectively across departments because they 
recognise that it’s in everyone’s interest.”  
(non-academia)
5.2.3 Opens up access to wider 
patient / user population
• Academics often have an existing pathway to patients 
and end users, either through direct partnerships 
with University Hospitals or previous clinical studies 
conducted. 
• Sometimes health tech development can occur in silo, 
disconnected from patient / user needs. Collaboration 
with academia can bridge the gap and connect 
developers to potential users.
“Academia can help to see if there’s appetite for your 
chosen population and can really help gather and 
analyse user experiences.” (academia)
5.3 Barriers to be overcome
5.3.1 Challenge of managing 
mutual expectations
• The definition of success of a project can be very 
different from an industry and an academic 
perspective. It can be a challenge to reach an agreed 
set of priorities between researchers and health tech 
companies, who can have different perceptions.
• There tends to be diverse and varied organisational 
strategy and vision across different commercial and 
academic organisations. Therefore, it is common to 
have differing visions and goals for a collaboration 
project, which can cause a barrier if they are not 
clearly defined and communicated early in the 
partnership. A key component to navigate this 
potential barrier is agreeing up a shared vision and 
strategic alignment.
• Robust research takes a long time. Globally, across 
industry and academia, there are frustrations and 
limits to collaborations due to the time it takes for 
research to be put into action.
• There is often a lack of understanding of the time 
required to fix a problem / develop a new iteration of 
technology innovations.
• There are always unexpected hurdles and barriers.
“You don’t know what you don’t know.” (non-academia)
 
5.3.2 Politics, protocol  
and governance
• Inter-organisational relationships can be complex and 
political, whether in industry or academia, and there 
may be various levels of sign off, people to convince of 
the value of such a collaboration.
• Internal organisational process, governance and 
finance are often complex and can cause delays, or 
indeed prevent a collaboration proceeding, if they are 
not clearly communicated or understood fully by key 
partners in the collaboration.
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• For scale up there is a requirement for enough 
flexibility within the technology and/or system to 
adapt to the different protocols, existing pathways 
and services across different hospitals / regions / 
healthcare systems / universities. This represents many 
potential pitfalls, delays and barriers to delivery of a 
successful project and adds to the issues of funding 
(by increasing start-up costs), evaluation of value (see 
funding, 3.3.5), inequity of care, and requirement for 
sign off at various levels.
5.3.3 Individual personalities 
and skills 
• Without the right combination of individuals with the 
right skills and traits to fulfil the various roles needed 
for the project to succeed, there can be major issues.
“As with any collaboration, the meld of personalities 
can make or break a project.” (academia)
5.3.4 Miscommunication 
between partners in the 
collaboration
• Lack of clearly defined communication channel(s) and 
no aligned communication pathway in universities or 
health boards leads to miscommunications & stepping 
on toes.
• Lack of clear communication within the departments 
responsible for process, governance, and finance. 
This is perceived to be especially true in larger 
organisations such as universities and health boards.
5.3.5 Restrictions and 
limitations on funding
• There is an issue around ownership in multi-partner 
collaborations: who is responsible for evaluations and 
getting academia involved? Where/Who does the 
funding come from?
• There is an assumption that a commercial profit-
making project doesn’t necessarily require high quality 
research to meet the certification requirements for 
sales. Therefore, it can be hard to see the need for a 
collaboration with academia.
5.3.6 Inconsistent language 
defining social sciences field
• Lack of standardised titles in social science academia 
leads to uncertainties around which speciality within 
the field is the right fit for potential collaborations. This 
tends to lead to health tech industry and implementing 
organisations having to rely on word-of-mouth and 
existing relationships to network effectively. 
“A friend’s post-doc’s flatmate was in the tech 
industry, so we reached out for an informal 
discussion.” (academia)
5.4 Key components of  
a good collaboration
Despite the variations between the types of projects 
discussed, and statements such as: “no one thing makes 
a collaboration successful” (non-academia), the following 
3 components were highlighted across all the interviews 
as important factor contributing to the success of the 
collaboration.
5.4.1 Good communication
• Communication style and technique enhances 
collaboration projects, the following aspects were 
highlighted:
 i. Clear, regular communication
 ii. Joint problem solving
 iii. Good sense of humour
5.4.2 Agreement on 
expectations and  
common motivation
• Co-production of something “good” with complete 
buy-in from both/all sides.
• Agreement and focus on the collaboration being 
essential to meet mutual need.
• Ensure everyone in the collaboration is on the same 
page with their expectations and have clear, realistic 
lead times at start of contract.
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5.4.3 Proactive investment  
in the relationship(s)
• Mutual respect, trust and reliance on each other’s 
expertise and belief everyone is trying to do the best 
they can.
• Team cohesiveness and everyone genuinely feeling 
that they are part of the same team.
• Every project discussed in the interviews incorporated 
a word-of-mouth element of how the collaboration 
started. 
“We’re a close-knit community in Wales.” (academia)
“We knew them.” (academia)
• Proactive investment in building a strong, long term 
relationship between collaboration partners.
“Relationships, it all comes down to relationships.”  
(non-academia)
5.5 Multi-Partner 
Collaborations
Most health tech industry and social sciences academia 
collaborations involved one or more other partners, most 
commonly an implementing partners such as the NHS, 
local authority, third sector or private care providing 
organisation. This creates additional benefits and barriers, 
some examples of which are outlined below.
5.5.1 Risk adverse 
organisations limiting 
opportunities for collaboration
• Innovation does not come without costs and risks, 
which can lead to low uptake of innovative technology 
in historically risk adverse public services (such as the 
NHS and local authority social care). Consequently, this 
limits the opportunities and demand for collaborations 
between health tech industry and academia.
“…but this is needed to give public services better tools - 
public services have put up with mediocracy for too 
long.” (non-academia)
• Similarly, Technology Enabled Care (TEC) is not a 
statutory requirement in social care – therefore use 
of it is an individual decision for each local authority, 
which equates to a lot of decisions makers across the 
country and has the potential to lead to inequity of 
care.
5.5.2 Need to prove 
value-added, increasing 
opportunities for collaboration
• Prevention is difficult to prove value / evaluate 
– especially in instances where the prevention 
technology is paid for out of a different budget than 
the cost of care it is preventing – i.e. local government 
social care cost Vs NHS health board cost. Social 
science academics in partnership with their clinical 
peers are best placed to lead this type of analysis and 
evaluation.
• Add in that the technologies implemented often have 
an economy of scale which is hard to accurately 
capture during a small-scale pilot project.
• How do you choose what “savings” to measure if you’ve 
stopped the deterioration of the individual such that 
they don’t even come into contact with the health 
services?
5.5.3 Advocates for change 
and innovation within 
implementing organisations 
are key to success
• A key supporter to champion for technology uptake 
within the NHS / third sector / local authority, are 
individuals who are willing, able, and capable to test, 
use and promote the use of specific technology. 
5.6 Impact of the  
COVID-19 pandemic
Despite it not being explicitly included in the interview 
discussion guide, during each interview there was 
reference to and examples shared of the impact of 
COVID-19 on these type of collaborations. On the whole, 
the consequences of the pandemic and response to it 
have led to reduction in a number of barriers outlined in 
the above section. Including the following: 
• Due to the increased immediate need for care to be 
delivered out of clinical settings let to increased use of 
technology to deliver and support health care at home, 
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there has been an increase in funding availability for 
collaborations. 
• In 3 of our 5 case studies, implementation of the 
technology was sped up due to COVID specific funding 
opportunities.
• Increased willingness of people across the spectrum, 
from clinical health care staff to general public, to 
utilise technology in every aspect of life, including 
health care. 
• COVID regulations and limitations on face-to-face 
interactions, forced health care provision to utilise TEC, 
which has opened doors for TEC providers to have 
productive discussions with the NHS. This in turn has the 
potential to increase opportunities for collaborations 
with academia as the NHS tend to require evaluation of 
innovations by a third party, independent partner with 
rigours, robust methodology and standards.
“It’s taken a pandemic for the NHS to fully realise that 
mobile phones are useful in supporting healthcare.” 
(non-academia)
5.7 Timing for initiation  
of collaborations
The interviewees were asked what they thought was 
the right point in the development process of a health 
tech for a collaboration with academia. The answers are 
captured in the following 3 quotes:
“As soon as possible” (non-academia, echoed by 
academia)
“Co-production of the technology is the way to go.” 
(academia)
“Early conversations lead to contributions at the right 
time. It’s difficult to backtrack once development has 
begun.” (academia)
However, there was a caveat that collaborations 
with social sciences academics are still beneficial 
post development of the technology because they 
enable improvements in the implementation and/or 
development of future iterations of the technology.
“Even when something is fully developed, social 
science is interested in how something functions in 
the real world and how the patients feel when using 
it.” (academia)
6. Case Studies 
From the interviews we have created the following 5 case 
study exemplars of successful collaboration projects 
exploring factors contributing to their success and 
barriers they navigated. 
These case studies are varied and diverse on all fronts, 
from the nature of the partner organisations to duration 
of project to size and scope of project. These varied 
examples were chosen to demonstrate that there are 
lots of opportunities for collaborations of different nature 
between social sciences academia and the health tech 
industry. There is no one size fits all or clear-cut model to 
be followed, which can be viewed as both an opportunity 
and barrier to new collaborations. 
The lack of clear-cut model to replicate is especially 
apparent when considering the diversity of how the 
collaborations were initiated:
1. PocketMedic – A mutual contact in the NHS, who had 
previously worked with both partners, facilitated an 
introduction between the social sciences academic 
and health tech industry.
2. BabyMind App – The social sciences academic 
reached out informally to a friend-of-a-friend in the 
tech industry to discuss feasibility of her idea.
3. COVID-19 Diagnostic – A funding opportunity led to 
a multi-partner team being formed based on the 
existing network of the academic leads.
4. TiM on MyPathway – The academic team had an 
existing tech product they wanted to be developed 
further and reached out into the health tech industry 
to an organisation with an existing product that had 
synergies.  
5. Delta Wellbeing CONNECT – A multi-partner non-
academic collaboration with growing number of 
interlinking projects, each offering unique opportunities 
for different social sciences academic collaborations 
to evaluate the tech services offered. The academic 
involvement has been initiated from pre-existing 
relationships between the university (or university 
department) and the non-academic partner 
organisation.
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5.3.1 Pocket Medic – COPD
Collaborators
Academic: Health Psychology Researcher– Liam Knox, 
Aberystwyth University
Health tech Company: PocketMedic, Kimberley Littlemore 
- Creative Director
NHS: Professor Keir Lewis at Hywel Dda University Health 
Board (HDUHB)
Background
PocketMedic started in 2014 as a small group of 
broadcast professionals with ambitions to make films 
to support people to better manage their chronic 
conditions. Hywel Dda University Health Board (HDUHB) 
approached PocketMedic to help with the challenge of 
communicating with people with type 2 diabetes who 
were not attending their patient education courses. 
HDUHB serves a large geographical area including many 
rural constituents and communities. Many people in these 
communities face difficulties with poor local transport 
links and, for many, there are substantial distances to 
travel to attend courses teaching. 
PocketMedic created 10 films covering various aspects of 
managing type 2 diabetes and evaluated them through 
the Diabetes Research Unit in Swansea University. The 
findings were published in Primary Care Diabetes1; people 
who watched the films had measurable improvements 
in their diabetes control and the more films people 
watched, the greater the improvement that was 
observed in their condition over a 3-month period. It 
started with educating about diabetes, and now there are 
just over 100 films covering 10-12 different conditions.
In 2014, at the start of this project, PocketMedic had 
academic evidence to support the effectiveness of 
the diabetes films but had not yet had the opportunity 
to replicate that research for the other conditions. 
Respiratory conditions were of particular interest to 
Consultant Professor Keir Lewis in HDUHB who wanted to 
find a solution to communicate with people with Chronic 
Obstructive Pulmonary Disease (COPD) and motivate 
them to better manage their respiratory conditions. In 
this group, the afore mentioned travel difficulties are 
compounded by people needing to also travel to receive 
supporting pulmonary rehabilitation and the fact that 
mobility may be hampered by the underlying medical 
condition. 
Through a collaboration facilitated by Professor Lewis, 
PocketMedic teamed up with an Aberystwyth University 
PhD student, Liam Knox. This enabled PocketMedic to 
evaluate the digital films, and Liam to use the data for his 
PhD thesis.
The Project
PocketMedic develop the content of their films based on 
existing robust academic research in Self-Determination 
Theory, which proposes that motivation and behaviour 
change occurs through 3 components: Autonomy, 
Competence, and Relatedness. The PocketMedic directors 
are strong advocates for the importance of independent 
evaluations to ensure their films are delivering the results 
they hope for and are open to honest feedback to help 
them continually improve their content. For this reason, 
they actively pursue and develop relationships with 
academics early in the development of new content. 
Liam had an interest in Self-Determination Theory and 
was keen to examine whether digital media could 
motivate people to self-manage more effectively and 
compare face-to-face learning with learning via films 
delivered on mobile devices. PocketMedic had ideas for 
two research projects, a clinical trial with about 50 people 
and a qualitative interview arm of 7 people, and Liam 
added on a third research project, with 72 participants, to 
form his thesis (PhD’s traditionally consist of 3 separate 
but related studies).
PocketMedic held the IP for the films which were already 
professionally developed and ready for use at the start 
of this project and they both had equal rights to the data 
from the research. 
Success
From the start of the collaboration there was a proactive 
investment in the relationship from both parties who were 
interested to explore the tenets of self-determination 
theory in the context of whether the PocketMedic 
films could motivate people to make changes in their 
behaviour:  Autonomy (they can do things based upon 
their own volition), Competence (they feel capable in 
1: A pilot service-evaluation examining change in HbA1c related to the prescription of internet-based education films for type 2 diabetes. S. Rice, H. 
Cranch, K. Littlemore, J. Mortimer, J. Platts, J.W. Stephens. Published: March 10, 2017 DOI: https://doi.org/10.1016/j.pcd.2017.02.002 
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an activity), and Relatedness (they feel they’re part of 
something). 
Liam joined the project to evaluate the COPD films. 
Interviewing the study participants about what was 
driving them to make a change in behaviour. Exploring 
whether self-determination theory was useful for 
predicting motivation for people with COPD. The 
findings of his research were positive, showing that 
the PocketMedic COPD films “ticked all the boxes” for 
engaging, motivating, and encouraging behavioural 
change in those who viewed them.
The PocketMedic team was delighted with the findings 
which were a clear endorsement of what they were 
trying to do and saw a huge value in the results from 
an unbiased independent academic researcher. This 
research has not only supported the use of PocketMedic’s 
COPD films but has also provided strong evidence for 
the wider roll out of PocketMedic’s content to support 
the existing programme of pulmonary rehabilitation in 
partnership with the NHS across Wales. Liam’s results and 
extracts from his research are being utilised to further 
PocketMedic’s work in grant applications and pitches to 
potential buyers of the films.
Barriers
PocketMedic have potentially positioned themselves 
ahead of other health tech companies by developing 
their content based on psychological theory and 
principles, and by incorporating discussions and 
evaluation plans with academics early in the 
development of their content. Involvement of academia 
at the idea stage can help gauge patient appetite 
early-on, gather and analyse user experiences to shape 
and inform development. There is increasing opinion 
that academic input should be gained at the start, 
yet there are a number of barriers which prevent this 
being common practice. These include barriers such as 
grant application processes, lengthy research approval 
processes, and a willingness to act upon academic 
suggestions, all of which the PocketMedic team faced 
and overcame.
5.3.2 BabyMind App
Collaborators
Academic: Professor Elizabeth Meins, York University & 
Fionnuala Larkin (Postdoctoral researcher)
Health tech Company: Lee McLaughlin, IC Mobile 
Funders: UK Research and Innovation (UKRI) Economic 
and Social Research Council (ESRC) Professorial 
Fellowship
Background
Over the last 20 years, Professor Elizabeth Meins, a 
developmental psychologist, has defined and led the 
research exploring “mind-mindedness” - a parent’s ability 
to ‘tune into’ or ‘read’ their babies’ thoughts and feelings. 
Research studies across the world found that early mind-
mindedness is an important predictor of wide-ranging 
positive aspects of children’s development. Given this 
positive impact, Professor Meins decided to investigate 
whether it was possible to use technology to intervene 
and teach parents how to become more mind-minded. 
The Project
In 2013/14, Professor Meins applied for, and was awarded, 
an UK Research and Innovation (UKRI) Economic and 
Social Research Council (ESRC) professorial fellowship 
to explore how to implement the proven research and 
teach parents how to become more mind-minded. She 
discussed the feasibility and viability of using an app to 
implement the intervention with a friend-of-a-colleague, 
Lee, who was an app developer. They decided use of an 
app was worth trialling, due to the gradual increase in 
use of such tools as interventions for mental health and 
psychological disorders, despite it not yet being utilised 
for delivery of interventions in parenting. 
At the time, parenting apps were being launched, but 
none had been trialled. Lee saw the ground-breaking 
potential of the project to develop evidence-based 
technology and “do good”. Professor Meins and her 
Postdoctoral researcher, Fionnuala Larkin, wrote the 
content for the app based on the results of research on 
parents’ mind-mindedness and things which had been 
demonstrated to help parents think more about their 
baby’s experience/perspective. Lee developed the App, 
API and Dashboard software to meet the study design 
requirements that the team wanted to test. Over a period 
of 3 months, the original version was trialled and tested 
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by the academics, with issues/bugs fed back to Lee to 
fix and further develop the app software, prior to sharing 
with the trial participants. 
This trial of the original version of the app was so 
successful that the team utilised the results to create a 
new version based on the trial results, which showed that 
the number of posts did not predict how mind-minded 
a parent was, rather it was whether they had the app 
and how much time per day they engaged with the app. 
These results enabled the removal of the resource heavy 
requirement for an academic to be actively responding 
to user’s posts. The new version (BabyMind) includes 
automated daily alerts with snippets of information about 
babies’ psychological development based on the baby’s 
age and is now free to download on the app store.
Success
The success of this project was built upon good 
communication, clear division of roles and responsibilities, 
and complete trust between the collaborators. This 
ensured a willingness to rely on each other’s expertise 
and give over control of the other’s tasks.
Technology enabled the parenting intervention 
developed to be delivered in a manner which was easily 
integrated into everyday life, encouraging parents to 
post photos and videos of their baby with the addition of 
developmental psychology education. The app removes 
the stigma often associated with parenting interventions 
i.e. that they need to go somewhere and have their “bad 
parenting” corrected. Instead, with this delivery platform, 
the intervention has become normalised and made more 
accessible to a wider audience. Without collaboration 
with the tech industry, it would not have been possible to 
access and help parents at the scale the BabyMind app is 
currently reaching. 
Anecdotally: 
A younger mother had her first baby taken into care. 
When she had her second baby, she was part of initial 
trial group with the BabyMind app and told her health 
visitor that the app had “completed transformed her 
life”. After using the App, when she was assessed, the 
baby was taken off the child protection register. 
In response to this anecdote, Professor Meins said: 
“That makes it all worthwhile - if we can just help 
one person be a more effective parent in really 
difficult circumstances. Just think, WOW, we’ve helped 
someone in the real world change the trajectory 
of that child and that mother’s life. Without it being 
easily accessible on a phone, I’m unsure this would 
have been possible, as for this mother to have got to 
a face-to-face intervention, things would have had to 
get much worse first. Instead, the technology enables 
us to catch people early, especially because it’s easy 
and fun.”
Barriers
The nature of the ESRC professorial fellowship funding, 
which had the overarching aim to translate academic 
research into ways to help parents in the real world, was 
an investment in Professor Meins as an individual. This 
overcame potential funding limitations / issues around 
fixed deliverables / targets, instead enabling the natural 
progression of developing iterations of the app based on 
the results and feedback from trial users, midwives, health 
visitors and other specialists. The funding encouraged 
collaboration with non-academic partners, which lead to 
strong relationships with health visitors, perinatal mental 
health services and mother-and-baby units, which 
further helped ensure the intervention was relevant and 
accessible to those who needed it most. 
5.3.3 COVID Diagnostic
Collaborators
Academic: Dr Daniel Rees, Swansea University 
NHS:  Local University Health Board
Health tech Company: Onkolyze ltd
Consultancy:  A respiratory health advice and research 
consultancy
Funders: Welsh Government SER CYMRU III- Tackling 
COVID-19 Grant
Background
Discussions between academics from Swansea University 
(SU) and Onkolyze Ltd, a MedTech company, who provide 
data driven solutions for diagnostics & prognostics in 
oncology, were ongoing prior to the COVID-19 pandemic.  
The pandemic led Onkolyze Ltd to repurpose their existing 
technology, which uses artificial intelligence (AI) to extract 
features, images and data from CT scans / ultrasounds / 
x-rays, to identify signs of COVID-19 from lung ultrasounds. 
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The Project
With an ongoing positive relationship between SU and 
Onkolyze Ltd during this period of repurposing, Onkolyze 
Ltd was able to reach out to their main contact at SU, 
Daniel Rees, who then utilised the university’s ecosystem 
and external network to build an interdisciplinary team. 
This strong team were selected due to their pre-requisite 
skills of having the experience to enable this agile 
innovation to implement an evaluation study on the NHS 
frontline.
The “dream team” for delivering this project comprised 
of individuals who came together with a desire to do 
the same thing and were known to each other through 
the “close-knit community” of Wales. The 9 members 
came from: Onkolyze Ltd; a multidisciplinary team from 
Swansea University (SU) including social scientists, clinical 
researchers, legal, ethical and financial specialists; 
clinical staff at the University Health Board; and a 
respiratory health advice and research consultancy. 
Academics from across SU faculties (School of 
Management and Medical School) were multidisciplinary 
in their approach with appreciation and experience in 
Research, Development & Innovation (RD&I), technology 
acceptance models, technology & knowledge transfer 
and innovation management in the Life Sciences Sector. 
There were 2 leads to this project; for the clinical aspect, a 
boundary-spanning clinical academic who worked within 
the university health board and Swansea University. 
For Swansea University, Dr Daniel Rees, an academic 
experienced in development and execution of multi-
disciplinary RD&I projects across Life Science Sector.
Success
A successful application for a Welsh Government 
COVID-19 specific grant supported a 6-month project 
to prove the diagnostic capability. Testing looked at AI 
detect signs of COVID-19 and accuracy to predict severity 
of infection from an ultrasound image of patient’s lungs 
captured with a handheld ultrasound device. Onkolyze 
Ltd created an AI algorithm which was trained using 80% 
of the longitudinal ultrasound images captured from 
80-90 patients on a COVID ward. The remaining 20% of 
the images were used to “test” the AI’s diagnostic ability 
which found that it could identify COVID-19 and classify 
severity from the ultrasound images with >96% accuracy. 
In addition, the AI technology developed through this 
study was capable of grading ‘severity’ of COVID-19 based 
on morphological features identified in ultrasounds 
images sweeps.
There were several reasons this collaboration worked 
so well. Firstly, the people, who had a shared vision with 
willingness to work together in an agile, responsive 
manner to deliver the project quickly. Secondly, the tight 
timeframe - from the wider external drive to develop 
something to improve diagnostics and prognostics of 
the new virus, to the funding requirements to implement 
the project, producing analysis and reporting of results 
in 6 months. Finally, clinical staff who were and are 
champions for the technology; willing and able to use 
and promote use of the innovative technology.
Barriers
A potential barrier, which was overcome by the 
responsive boundary-spanning project team 
members, was a clear and deep understanding of 
the governance, process and finance requirements 
across each organisation within the collaboration. This 
helped to navigate potential miscommunications within 
organisations by ensuring clearly defined responsibilities 
and aligned communication pathways to prevent 
too many people trying to handle internal processes, 
particularly within the large organisations. Achievement 
of this required a focused project manager to ensure 
each step of the various processes were happening 
smoothly.
5.3.4 TiM on MyPathway
Collaborators
Academic: Health Psychology Researcher – Liam Knox at 
the Sheffield Institute for Translational Neuroscience at 
the University of Sheffield (SITraN)
Health tech Company: ADI - Advanced Digital 
Innovations in Health
Funders: MND Scotland – Motor Neuron Disease Scotland 
& SBRI - Small business Research Institute
Background
Telehealth in Motor Neuron Disease (TiM) on ADI’s 
MyPathway mobile and desktop app, is a clinical 
management system and digital health communication 
platform. TiM on MyPathway supports the carers of, and 
people with Motor Neuron Disease (MND) in a variety of 
ways, including virtually/digitally connecting them to 
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specialist MND Centres and complimenting their existing 
care. TiM on MyPathway collects a holistic view of patient 
reported data via questionnaires and is a space where 
reliable information can be found to support patient 
self-management, remote monitoring and waiting list 
management. 
Academics at SITraN developed the initial version of TiM 
and wanted to further the research and expand its use 
within the NHS. The collaboration between SITraN and 
ADI arose when the university researchers identified 
the need for a technology company to help develop a 
service for people with MND. ADI, a health consultancy 
specialising in digital healthcare solutions, already 
delivered remote early intervention and support services 
for musculoskeletal (MSK) conditions in the Sheffield area 
so were the obvious choice partner. ADI had an existing 
platform called MyPathway implemented in the NHS 
as a communications channel connecting patients to 
clinicians.
The Project
SITraN and ADI applied for and were awarded a grant 
from MND Scotland to support the collaboration to 
develop, implement, and evaluate the TiM on MyPathway 
App within NHS centres in Sheffield and Edinburgh.
The social science contribution to the project was health 
psychology research focussed, led by Liam Knox. The 
research firstly reviewed the implementation of the App 
(completed), and secondly, it is looking to evaluate the 
effectiveness of the App from the perspective of people 
with MND, carers and healthcare professionals (ongoing).
When the COVID-19 pandemic hit, the 6-month 
development period was accelerated to just 6 weeks due 
to COVID-19 causing the whole model of care to change. 
The original hope was to conduct a lot of user testing and 
release a finalised version of the App into the centres. 
Instead, a more basic version was released and changes 
were made iteratively. 
Additionally, the “COVID-19 Pandemic Rapid Response” 
funding enabled other specialist MND centres 
and academics to join the project. Including an 
implementation project in Ireland, which was led 
and evaluated by Trinity College Dublin, where TiM 
on MyPathway is actively being used by 30 patients 
to provide a link between hospital and community-
based services, plan their clinic visits to align to their 
relevant issues and enable ongoing communication 
with specialist nurses. The findings from this study will 
feedback into future iterations of the App and inform 
localisation requirements for future roll out in Ireland. 
Success
Evaluation of technical capability as well as functionality 
of the App are ongoing but overall, the collaboration 
is working very well and there was a perfect match of 
attitude amongst people who wanted to make it work. 
Regular communication between Liam and ADI, was 
helped by ADI’s willingness to have ad hoc meetings. 
MND Scotland, who are funding the development 
and research, has enabled the team space to make 
modifications to the initial proposal, with their help 
available when needed. 
In terms of IP, it is split. ADI own the background IP of their 
MyPathway platform, which TiM is built and runs within. 
Whereas the MND-specific clinical expertise is owned by 
SITraN. As a collaboration, this means that ADI receive 
valuable feedback on how to develop and refine the 
platform without running the risk of using inappropriate 
content or questions for the clinical condition.
Team cohesiveness has played a vital role in this 
collaboration: “by making sure everyone genuinely feels 
part of the same team and believes that each party is 
trying to do the best they can.”
Barriers
The main barrier was resourcing and delivering the 
ambition of the project, with costs that were more than 
the funding available. The MND Scotland grant money 
was spent twice over, fortunately additional funding from 
SBRI and Innovate UK was received to do beta trials. ADI 
were committed to making it work, but as a company 
other demands and priorities are time-consuming. The 
aim is to sustain the project post-funding in 2022 and 
transition to being a commercially viable platform. 
ADI potentially could offer the tool to new centres near 
enough at cost price, so centres would only need to 
purchase a licence fee and ADI’s long-term commercial 
outlook may result in long-term benefits for patients. 
Unforeseen delays were a challenge for the project 
team, difficulties in predicting how long technical issues 
would take to rectify were taxing when collaborating with 
somewhat inflexible NHS systems and schedules. 
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5.3.5 Delta Wellbeing CONNECT
Collaborators
NHS: Hywel Dda University Health Board (HDUHB) 
Health tech Implementation Organization:  
Delta Wellbeing  
Health tech Company: Tunstall 
Local Authority: Social Care Departments in Ceredigion, 
Carmarthenshire and Pembrokeshire County Councils
Academics: Aberystwyth University 
Background
Delta Wellbeing were one of the recipients of the Welsh 
Government Transformation Fund1, to implement and 
evaluate whether their CONNECT project could improve 
health and social care services. The Delta Wellbeing 
CONNECT project seeks to transform the way social care 
is delivered, implementing a new model of self-help and 
proactive care by offering flexible support packages, 
tailored towards an individual’s specific needs, to improve 
wellbeing, helping people to stay independent for longer 
and reduce demands on long-term or acute health and 
social care.  It utilises Technology Enabled Care (TEC), 
such as red button lifelines, fall detectors, GPS tracking 
devices, door sensors and medication dispensers.
CONNECT focuses on supporting prevention and 
wellbeing through a technological and digital approach 
providing a wrap-around service to clients which 
includes; Pro-active wellbeing calls, digital support and 
TEC packages, keyworker support, guidance & wellbeing 
plans and access to 24/7 Community Welfare Response. 
Through the pro-active wellbeing calls Delta Wellbeing 
are able to check on the client’s general wellbeing and 
identify any significant changes in their circumstance as 
well as identify possible triggers for crisis. The regular calls 
can focus on their wellbeing plan or can follow guided, 
specific questions from clinicians to identify patterns or 
trends linked to health conditions. 
The 24/7 Response service is a non-medical emergency 
team to support with non-injurious falls, welfare support, 
non-response from sensor activations and many other 
non-medical requests for assistance. This service 
supports clients who do not have family/contacts, those 
where their contacts are unable to attend or where 
medical intervention is not required to stop inappropriate 
requests for ambulance teams to be dispatched.  
The NHS is under ever increasing pressures to improve 
care and support for patients with long term conditions, 
integrating TEC where possible to increase the ability 
to provide good quality care and support at home. 
The necessity to provide care out of the clinical setting 
increased exponentially with the COVID-19 pandemic. This 
has significantly contributed to an increased willingness 
to use technology to support independent living, home 
care, and replace clinical interventions when possible.
Technology Enabled Care (TEC) has changed a great 
deal in the last 5 to 10 years. From a reactive service being 
able to tell when something has happened to a client, 
to a true proactive service where trends and equipment 
algorithms can predict a down turn in a client’s health. 
The use of TEC and sharing information gathered by 
TEC and other health and social care platforms, Delta 
Wellbeing should be able to keep clients safer at home, 
return client home at the earliest opportunity after a 
hospital and use the date to support a client before they 
enter an acute setting.
The Project
The transformation fund enabled Delta Wellbeing 
CONNECT to expand and become more proactive, not 
only responding to emergencies but utilising additional 
technology to support the changing needs of people 
living independently at home. This service became part 
of the Hywel Dda University Health Board (HDUHB) NHS 
digital portfolio, where social care meets health, with 5 
key strands:
1. Monitor compliance – i.e. are patients completing their 
prescribed exercise / monitoring their glucose levels etc.
2. Monitor the frail elderly population with basic 
measurements (including gait, hydration, temperature) 
taken using technological tools, enabling proactive risk 
stratifying of the population.
3. End-of-life care - monitoring basic measurements to 
detect deterioration earlier and reduce admissions 
into A&E / clinical settings.
4. Supported discharge from hospital, with technology 
placed into the home to support rehabilitation and 
monitoring. 
1: The Welsh Government Transformation Fund aims to improve health and social care services by funding the additional costs associated with 
introducing new models of care, replacing and reconfiguring existing services.
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5. Unlock the potential to proactively prevent hospital 
admissions by creating a framework to predict 
the patients at greatest risk of attending A&E in the 
imminent future. 
Directors in HDUDB, including the Director of Finance, Huw 
Thomas, recognised the opportunity to monitor people’s 
health and wellbeing through Delta Wellbeing’s technology 
and decided to directly invest in a number of pilot projects 
to fully evaluate the potential. One of these pilot projects 
incorporates interventions which align with existing 
services for patients with COPD, focusing on encouraging 
and monitoring patient’s ability to exercise effectively.
Success
All organisations involved in the collaboration are fully 
engaged and keen to develop TEC to support better 
health and social care, enabling individuals to remain 
living independently and out of hospital with good health, 
wellbeing and support. 
The COPD pilot is running successfully so far, with all 
partners aligned. The location chosen for the pilot was a 
region of deprivation with an industrial past which has left 
a legacy of lung related issues, providing an opportunity 
for the TEC trial to make an impact. Additionally, there 
is support from a GP in the region who is keen to 
incorporate new technology to improve care. 
To identify and choose the right technology for this pilot, 
and other TEC services, HDUHB and Delta Wellbeing are 
in an ongoing dialogue with the health tech company 
Tunstall. They are looking to understand what technology 
options are available, what it can be used for and 
determining which would be most effective in supporting 
various conditions. 
The COPD pilot will be evaluated by health psychology 
academics from Aberystwyth University who have 
a depth of experience in researching interacting 
with technology effectively. HDUHB has collaboration 
agreements with universities located in the region, 
including Aberystwyth University, University of Wales 
Trinity St David, and Swansea University. These 
agreements are the legal backbone of the ongoing 
conversations and positive relationships between the 
NHS and academia in the region. This ongoing dialogue 
is essential for each side to better understand what the 
other does and over time get to a space where you know 
each other’s strengths and weaknesses. 
Barriers
Understandably the NHS need to prove cost effectiveness 
to widen implementation of any new service, however 
prevention of events or admissions is a challenge to 
capture - how do you capture the numbers of what you 
have stopped from happening? This creates a potential 
limit on the use of new technology within the NHS due to 
rapid innovation in the technology industry outrunning 
the ability to prove value, especially for interventions that 
have preventative, holistic aims of keeping people in their 
own homes and living independently.  
TEC pilots within the NHS have strict regulatory and 
governance requirements. Such protocols are of course 
reasonable barriers to ensure patients wellbeing remains 
top priority. Ethical issues can be a barrier when running 
pilots within the NHS which have the potential to lead to 
inequities of care between patients in the pilot versus 
those on the regular pathway. 
Finally, it is extremely important that the patients and the 
wider multidisciplinary team, involved in their care and 
management, are on board with the technology. They 
need to be able to see potential benefits before they are 
proven and be willing to test a new approach, which may 
require additional training and time to implement and 
monitor effectively.  
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7. Conclusions
This report has explored the barriers and benefits of 
collaborations between social sciences academia and 
health tech industry, concluding that there are great 
advantages to been seen within and as a result of 
these type of collaborations. These include, increasing 
accessibility to robust evidence-based interventions; 
delivery of independent credible analysis and 
evaluations; and linking the development of health tech 
with potential users.
However, there are also significant barriers to 
navigate and overcome. These include, managing 
mutual expectations; clear understanding of process, 
governance and politics within each partner in the 
collaboration; limitations and restrictions on funding; and 
inconsistent language defining social sciences field.
The advantages are worth navigating potential barriers 
for, by clearly communicating expectations, process 
outcome requirements, funding restrictions and 
proactively pursuing an open, trusting relationship. 
Relationships between individuals within the collaboration 
were stated as the most important factor for a successful 
project by everyone we interviewed. 
The diverse nature and differences amongst the 5 
case study exemplars shared in this report highlight 
the wide variety of potential drivers for collaboration, 
funding routes and points of entry for social sciences 
into projects. This ranges from the point of entry being 
proactively with the stakeholder, such as in the BabyMind 
App case study, where academics engaged directly 
with the health tech industry as the tech provider and 
developer. In total contrast to this, the Delta Wellbeing 
CONNECT case study demonstrates the opportunity 
for academic engagement with some of the multiple 
stakeholder’s who were involved a large and complex 
project where industry, the local authority and NHS are 
working to develop and implement technology together. 
This variation in exemplars reinforces that social sciences 
academics should never discount any potential routes 
for collaborations, they can exist even where not obvious 
on first sight. Of course, this makes collaboration an even 
greater challenge when there is not always an obvious 
route and where funding streams and expectations will 
differ depending on the specific approach and drivers of 
each collaboration. 
Currently, the greatest challenge to overcome in 
encouraging new collaborations is that the majority are 
built upon existing relationships between social sciences 
and industry, or introductions via word-of-mouth 
recommendations. Further, with the move to virtual 
conferences instead of in-person events, opportunities 
to informally network are limited. This puts an increased 
reliance on individuals to be proactive and already 
connected into organisations such as ASPECT, ABPI, 
MediWales, etc.
The hope is that this research and report will contribute 
to increasing the awareness of existing collaborations, 
the benefits to be gained from both perspectives and the 
barriers to be considered and overcome. Additionally, the 
huge diversity shown across the 5 case studies presented 
demonstrates the different types and approaches to 
these collaborations. We recommend regular sharing 
of the many and varied ongoing and past successful 
collaboration projects through reports, case studies and 
webinars to encourage discussions and spark  
innovative ideas.  
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